Follow
Mark A Hallman
Mark A Hallman
Assistant Professor, Fox Chase Cancer Center
Verified email at fccc.edu
Title
Cited by
Cited by
Year
Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman
World journal of clinical oncology 8 (1), 1, 2017
2652017
Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells
SM Knoepp, MS Chahal, Y Xie, Z Zhang, DJ Brauner, MA Hallman, ...
Molecular pharmacology 74 (3), 574-584, 2008
832008
Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer
NG Zaorsky, T Shaikh, CT Murphy, MA Hallman, SB Hayes, ML Sobczak, ...
Cancer treatment reviews 48, 50-60, 2016
612016
Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
NG Zaorsky, T Shaikh, K Ruth, P Sharda, SB Hayes, ML Sobczak, ...
Clinical genitourinary cancer 15 (2), 326-335. e3, 2017
532017
Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor
MA Hallman, S Zhuang, RG Schnellmann
Journal of Pharmacology and Experimental Therapeutics 325 (2), 520-528, 2008
502008
Long-term patient-reported outcomes from a phase 3 randomized prospective trial of conventional versus hypofractionated radiation therapy for localized prostate cancer
T Shaikh, T Li, EA Handorf, ME Johnson, LS Wang, MA Hallman, ...
International Journal of Radiation Oncology* Biology* Physics 97 (4), 722-731, 2017
472017
A phase II trial of risk enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN BLADDER): Interim analysis.
DM Geynisman, P Abbosh, EA Ross, MR Zibelman, P Ghatalia, F Anari, ...
Journal of Clinical Oncology 39 (6_suppl), 397-397, 2021
362021
Effect of antioxidants on para-aminophenol-induced toxicity in LLC-PK1 cells
MA Hallman, R Tchao, JB Tarloff
Toxicology 156 (1), 37-45, 2000
342000
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer
V Avkshtol, Y Dong, SB Hayes, MA Hallman, RA Price, ML Sobczak, ...
Research and reports in urology 8, 145, 2016
302016
Ten-year update of a randomized, prospective trial of conventional fractionated versus moderate hypofractionated radiation therapy for localized prostate cancer
V Avkshtol, KJ Ruth, EA Ross, MA Hallman, RE Greenberg, RA Price Jr, ...
Journal of Clinical Oncology 38 (15), 1676, 2020
292020
Tissue TGF-β expression following conventional radiotherapy and pulsed low-dose-rate radiation
JE Meyer, NK Finnberg, L Chen, D Cvetkovic, B Wang, L Zhou, Y Dong, ...
Cell Cycle 16 (12), 1171-1174, 2017
262017
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
SB Johnson, PR Soulos, TD Shafman, CA Mantz, AP Dosoretz, R Ross, ...
Radiotherapy and Oncology 121 (2), 294-298, 2016
262016
Absence of pathological proof of cancer associated with improved outcomes in early-stage lung cancer
T Shaikh, TM Churilla, CT Murphy, NG Zaorsky, A Haber, MA Hallman, ...
Journal of Thoracic Oncology 11 (7), 1112-1120, 2016
182016
Patient reported outcomes among treatment modalities for prostate cancer
ME Johnson, NG Zaorsky, JM Martin, K Ruth, RE Greenberg, RG Uzzo, ...
Can J Urol 23 (6), 8535-45, 2016
172016
Contemporary trends in the utilization of radiotherapy in patients with renal cell carcinoma
T Shaikh, EA Handorf, CT Murphy, A Kutikov, RG Uzzo, M Hallman, ...
Urology 86 (6), 1165-1173, 2015
142015
Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer
Y Dong, NG Zaorsky, T Li, TM Churilla, R Viterbo, ML Sobczak, ...
Journal of medical imaging and radiation oncology 62 (1), 116-121, 2018
132018
RasGRP1 confers the phorbol ester-sensitive phenotype to EL4 lymphoma cells
S Han, SM Knoepp, MA Hallman, KE Meier
Molecular pharmacology 71 (1), 314-322, 2007
132007
Local control and toxicity of external beam reirradiation with a pulsed low-dose-rate technique
CT Lee, Y Dong, T Li, S Freedman, J Anaokar, TJ Galloway, MA Hallman, ...
International Journal of Radiation Oncology* Biology* Physics 100 (4), 959-964, 2018
102018
Identification of oncological characteristics associated with improved overall survival in patients with adrenocortical carcinoma treated with adjuvant radiation therapy …
KB Ginsburg, AA Chandra, JP Schober, EA Handorf, RG Uzzo, ...
Urologic Oncology: Seminars and Original Investigations 39 (11), 791. e1-791. e7, 2021
82021
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes
JJ Paly, BL Egleston, JK Wong, N Burbure, ML Sobczak, SB Hayes, ...
American Journal of Clinical Oncology 44 (4), 131-136, 2021
72021
The system can't perform the operation now. Try again later.
Articles 1–20